Secukinumab improves hand, foot and nail lesions in moderate-to-severe plaque psoriasis: subanalysis of a randomized, double-blind, placebo-controlled, regimen-finding phase 2 trial
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Secukinumab improves hand, foot and nail lesions in moderate-to-severe plaque psoriasis: subanalysis of a randomized, double-blind, placebo-controlled, regimen-finding phase 2 trial
Authors
Keywords
-
Journal
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
Volume 28, Issue 12, Pages 1670-1675
Publisher
Wiley
Online
2014-01-07
DOI
10.1111/jdv.12359
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomised, double-blind, placebo-controlled, phase II regimen-finding study
- (2012) P. Rich et al. BRITISH JOURNAL OF DERMATOLOGY
- Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study
- (2012) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- A 24-week randomized clinical trial investigating the efficacy and safety of two doses of etanercept in nail psoriasis
- (2012) J.P. Ortonne et al. BRITISH JOURNAL OF DERMATOLOGY
- Clinical improvement and satisfaction with biologic therapy in patients with severe plaque psoriasis: results of a European cross-sectional observational study
- (2012) Enno Christophers et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Investigator-initiated, open-label trial of ustekinumab for the treatment of moderate-to-severe palmoplantar psoriasis
- (2012) Shiu-Chung Au et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Advances in the treatment of moderate-to-severe plaque psoriasis
- (2011) R. N. Herrier AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Efficacy of Ustekinumab in Nail Psoriasis and Improvement in Nail-Associated Quality of Life in a Population Treated with Ustekinumab for Cutaneous Psoriasis: An Open Prospective Unblinded Study
- (2011) D. Rigopoulos et al. DERMATOLOGY
- Latitude and psoriasis prevalence
- (2011) Christine C. Jacobson et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Adalimumab for Treatment of Moderate to Severe Chronic Plaque Psoriasis of the Hands and Feet
- (2010) Craig Leonardi et al. ARCHIVES OF DERMATOLOGY
- Efficacy of Ustekinumab in Palmoplantar Psoriasis
- (2010) C. Bulai Livideanu et al. DERMATOLOGY
- Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis
- (2010) W. Hueber et al. Science Translational Medicine
- Sustained improvement in joint pain and nail symptoms with etanercept therapy in patients with moderate-to-severe psoriasis
- (2009) TA Luger et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Approach to managing patients with nail psoriasis
- (2009) K Reich JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Treatment of nail psoriasis with adalimumab: an open label unblinded study
- (2009) D Rigopoulos et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Psoriasis treatment in difficult locations: scalp, nails, and intertriginous areas
- (2008) Gottfried Wozel CLINICS IN DERMATOLOGY
- Guidelines of care for the management of psoriasis and psoriatic arthritis
- (2008) Alan Menter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started